Search results
Viatris' Mylan Recalls One Lot Of Octreotide Acetate Injection Due To Glass Particulates
Benzinga via Yahoo Finance· 2 years agoViatris Inc's (NASDAQ: VTRS) Mylan is voluntarily recalling one lot of Octreotide Acetate Injection,...
Novartis (NVS) Lutathera Meets Primary Goal in Phase III Study
Zacks via Yahoo Finance· 8 months agoNovartis' (NVS) radioligand therapy Lutathera reports statistically significant and clinically...
Amryt (AMYT) Mycapssa Gets Orphan Drug Tag for Carcinoid Syndrome
Zacks via Yahoo Finance· 2 years agoAmryt Pharma plc AMYT announced that the FDA has granted Orphan Drug designation to its marketed...
Novartis details first-line data for radiopharma drug Lutathera
BioPharma Dive via Yahoo Finance· 4 months agoPhase 3 trial results showed Lutathera cut the risk of disease progression or death by 72% as...
Novartis bags paediatric FDA label expansion for Lutathera
Pharmaceutical Technology via Yahoo Finance· 1 month agoNovartis has received a US Food and Drug Administration (FDA) approval for the label expansion of...
9 Causes of Hematemesis
Verywell Health via Yahoo News· 1 year agoThrowing up drops of blood or blood clots is a medical emergency SDI Productions / Getty Images Medically reviewed by Jay N. Yepuri, MD, MS "Hematemesis"...
Italian Privately Held Chiesi Farmaceutici To Acquire Amryt Pharma For $1.25B
Benzinga via Yahoo Finance· 1 year agoItalian family-controlled global pharmaceutical company Chiesi Farmaceutici S.p.A. has agreed to...
Crinetics (CRNX) Stock Surges 70% in a Month: Here's Why
Zacks via Yahoo Finance· 8 months agoCrinetics (CRNX) surges 69.6% in a month due to encouraging results from its late-stage study,...
Drug, blood pressure medication recalls: Full list of FDA recalls since 2012
USA TODAY via Yahoo News· 1 year agoMore than 1,321 recalls were issued last year for human drug products that were defective or violated laws enforced by the U.S. Food and Drug Administration. It’s the highest figure in the past ...
Crinetics soars on 'picture perfect' data for hormonal disorder drug
Reuters via Yahoo News· 8 months ago(Reuters) -Shares of drug developer Crinetics Pharmaceuticals jumped about 72% on Monday after its experimental treatment for a rare hormonal disorder not only succeeded, but performed better ...
